Literature DB >> 5473611

Ultrastructural study of two cases of alpha-chain disease.

J Scotto, H Stralin, J Caroli.   

Abstract

Intestinal biopsies of two patients with alpha heavy-chain disease were examined by electron microscopy. Except for a few differences, cells involved by the malignant neoplasia of the small intestine were similar and belonged to the plasma cell line and were, in fact, more like the cells observed in typical multiple myeloma. It is not surprising to find such cells in a disease which is characterized by the presence of alpha heavy chain in the serum since plasma cells are considered to be the main source of immunoglubulins. Moreover, the association of an intestinal plasmacytic neoplasia with the heavy chain of the immunoglobulin A in the serum agree with what is known of the normal synthesis by most of the plasma cells of the digestive tract of this immunoglobulin. Since lymphocytes can synthesize immunoglobulins and plasma cells probably originate from lymphocytes, too great an importance should not be attributed to morphological classification. Only an obvious, functional characteristic seems really useful for differentiation.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5473611      PMCID: PMC1553106          DOI: 10.1136/gut.11.9.782

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  The synthesis of immunoglobulin-g by cultured human lymphocytes.

Authors:  N Lobb
Journal:  Aust J Exp Biol Med Sci       Date:  1968-08

2.  A unique lymphoproliferative disorder associated with an IgM platelet agglutinin, diffuse hypergammaglobulinemia, amyloid deposition and excessive urinary excretion of IgG fragments.

Authors:  R W Colman; C K Osterland; R F Dorfman; H Chaplin
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

3.  Alpha-chain disease: a new immunoglobulin abnormality.

Authors:  M Seligmann; F Danon; D Hurez; E Mihaesco; J L Preud'homme
Journal:  Science       Date:  1968-12-20       Impact factor: 47.728

4.  Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease").

Authors:  J C Rambaud; C Bognel; A Prost; J J Bernier; Y Le Quintrec; A Lambling; F Danon; D Hurez; M Seligmann
Journal:  Digestion       Date:  1968       Impact factor: 3.216

5.  Electron microscopic studies of human leukemia and lymphoma.

Authors:  L Dmochowski; T Yumoto; C E Grey; R L Hales; P L Langford; H G Taylor; E J Freireich; C C Shullenberger; J A Shively; C D Howe
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

6.  Plasmacytic reticulum cell sarcoma. Case report with electron microscopic studies.

Authors:  H Okano; H A Azar; E F Osserman
Journal:  Am J Clin Pathol       Date:  1966-11       Impact factor: 2.493

7.  [Ultrastructure and function of the cells involved in the immunity reaction].

Authors:  J P Thiery
Journal:  Bull Soc Chim Biol (Paris)       Date:  1968-09-28

8.  Electron microscopic study of human leukemic cells in tissue culture.

Authors:  E De Harven; B Clarkson; A Strife
Journal:  Cancer       Date:  1967-06       Impact factor: 6.860

9.  Cytoplasmic and intranuclear electron-dense bodies in the myeloma cell.

Authors:  J E Maldonado; A L Brown; E D Bayrd; G L Pease
Journal:  Arch Pathol       Date:  1966-06

10.  "Intermediate" cell types and mixed cell proliferation in multiple myeloma: electron microscopic observations.

Authors:  J E Maldonado; R A Kyle; A L Brown; E D Bayrd
Journal:  Blood       Date:  1966-02       Impact factor: 22.113

View more
  3 in total

Review 1.  Immunoglobulins and the gut.

Authors:  E A Jones
Journal:  Gut       Date:  1972-10       Impact factor: 23.059

2.  Alpha-chain disease in subSaharan Africa.

Authors:  B H Novis; L B Kahn; S Bank
Journal:  Am J Dig Dis       Date:  1973-08

3.  Five cases of alpha chain disease.

Authors:  W F Doe; K Henry; J R Hobbs; F A Jones; C E Dent; C C Booth
Journal:  Gut       Date:  1972-12       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.